Join industry leaders at HLTH 2023 on October 8-11 in Las Vegas - featuring the NEW Pharma & Life Sciences Insights Program – for a deep dive into the world of digital technologies. Register here!
AstraZeneca’s promotion of Breztri Aerosphere has landed it in hot water with the FDA. The agency says an AstraZeneca sales aid made “misleading” claims about the effect of the inhaler on all-cause mortality, prompting it to send a warning letter to CEO Pascal Soriot.
The path to potential approval for bluebird bio’s lovo-cel has become slightly smoother after the FDA confirmed it will not be holding an advisory committee meeting before making a decision on the sickle cell disease gene therapy in December.
Cruising on the midstage clinical success of a brain cancer therapy, Day One Biopharmaceuticals is using the wind at its sails to bolster the back of its pipeline with a $3 million upfront deal for Sprint Bioscience's preclinical program.
The U.S. Chamber of Commerce last month filed a lawsuit in an attempt to hold up the IRA's price negotiations, a move the DOJ criticized in its recent motion to dismiss.
Precision BioSciences has moved quickly to partner its CAR-T cell therapy candidate. Nineteen days after confirming it planned to partner the program, the biotech has agreed to offload the asset to Imugene for $21 million upfront and much more on the back end.
Two years after a high-frequency version of Nevro’s neurostimulation system became the first spinal cord stimulator approved by the FDA with a specific indication to treat pain associated with diabetic neuropathy, the company has published long-term study data further backing up the regulator’s decision.
Concern over the cost of prescription drugs is becoming less of a policy issue and more of a “core value” for voters across party lines, a pollster found. Two pollsters presented results from their recent survey on Tuesday.
From the team behind Fierce Pharma, Fierce Biotech, and Fierce Healthcare, Fierce Life Sciences Events. Explore our up-coming events this Fall, there's something for everyone! Secure your spot and save today!
Learn how process liquids and buffers impact your total cost of ownership (TCO) and how outsourcing can revolutionize your approach, ensuring quality standards and improving productivity.
Sponsored by: Thermo Fisher Scientific Process Liquid Preparation Services
In oncology, traditional methods for determining sales force size & structure are no longer appropriate. This paper describes the multiple drivers of sales strategy in oncology markets today.
Sponsored by: Blue Matter, strategic consultants in the life sciences
Learn more about how you can improve the productivity of your research and manufacturing operations and accelerate the journey from laboratory to saving lives.
Learn how the right chemical inventory strategy helped save a mid-size CDMO millions of dollars while securing a stable supply of products with just-in-time delivery.
Sponsored by: Thermo Fisher Scientific Production Chemicals and Services
Download this webinar to learn how to avoid pitfalls when characterizing CAR-T cells in your development workflow, how to save time by using one antibody to examine your entire panel of CARs, and more.
